Status:
COMPLETED
Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium
Lead Sponsor:
GlaxoSmithKline
Conditions:
Pain
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
This research study is being conducted to characterize the pharmacokinetic properties of a new topical medication (MFC51123) that contains two active ingredients (diclofenac and menthol) in two formul...
Eligibility Criteria
Inclusion
- Participants aged 18 to 50 years
- Body mass index between 19-28 (kg/m2)
Exclusion
- Pregnant or lactating females
- Participants having intolerance or hypersensitivity to study material
- Participants having positive results for HIV, Hepatitis B or Hepatitis C
- Participants having skin lesion at site of application
- Participants having history of alcohol or drug abuse
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 21 2014
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02201238
Start Date
October 1 2014
End Date
November 21 2014
Last Update
June 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Buffalo, New York, United States, 14202